Markets & Regulations

Pic: getty/geritK

WHO validates 11th COVID-19 vaccine

By Rachel Arthur

The World Health Organization (WHO) has today issued an emergency use listing (EUL) for Convidecia, a vaccine manufactured by CanSino Biologics, bringing the total number of COVID-19 vaccines validated by the organisation to 11.

Pic:getty/richarddrury

Nurturing biotech in Europe: EuropaBio sets out recommendations

By Rachel Arthur

EU systems need to become more streamlined to help bring novel technologies to market - which would in turn encourage investment and activity in healthcare biotech, says EuropaBio as it publishes key policy recommendations for the sector.

Pic:getty/oatawa

Astorg to acquire CordenPharma from ICIG

By Rachel Arthur

Astorg will acquire CDMO CordenPharma from ICIG: noting strong organic growth for the CDMO thanks to its position in fast-growing drug modalities such as mRNA vaccines, peptides and high-potency compounds notably for oncology therapeutics.

Pic:getty/jonathankitchen

Merck Q1: Keytruda sales up 23%

By Rachel Arthur

Merck’s cancer drug Keytruda continues to grow: helping Merck record ‘robust top-line and bottom-line growth’ across the company in Q1 2022.

© GettyImages/Olivier Le Moal

Amneal secures second US biosimilars approval

By Jane Byrne

Last week saw the US Food and Drug Administration (FDA) approve the Biologics License Application (BLA) from Amneal Pharmaceuticals Inc for bevacizumab-maly, a biosimilar referencing Avastin, the Roche/Genentech product.